QC
AVNS

Quadrature Capital’s Avanos Medical AVNS Stock Holding History

Quadrature Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,296
Closed -$161K – 1370
2025
Q4 		$161K Buy
+14,296
New +$164K ﹤0.01% 1013
2024
Q3 		– Sell
-13,313
Closed -$266K – 968
2024
Q2 		$266K Sell
13,313
-299
-2% -$5.82K ﹤0.01% 862
2024
Q1 		$271K Sell
13,612
-9,595
-41% -$185K ﹤0.01% 942
2023
Q4 		$521K Buy
23,207
+9,320
+67% +$192K 0.01% 658
2023
Q3 		$281K Buy
+13,887
New +$315K 0.01% 754
2022
Q2 		– Sell
-7,884
Closed -$264K – 730
2022
Q1 		$264K Buy
7,884
+1,379
+21% +$44.4K 0.01% 548
2021
Q4 		$226K Sell
6,505
-4,227
-39% -$137K 0.01% 555
2021
Q3 		$335K Buy
+10,732
New +$364K 0.01% 472
2021
Q2 		– Sell
-4,700
Closed -$206K – 939
2021
Q1 		$206K Buy
+4,700
New +$221K 0.01% 749
2016
Q4 		– Sell
-13,235
Closed -$459K – 610
2016
Q3 		$459K Buy
+13,235
New +$464K 0.04% 374

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Quadrature Capital's AVNS Position: Q1 2026 in Review

Quadrature Capital sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 14,296 shares — an estimated $161K sold.

Quadrature Capital first reported a position in AVNS in Q3 2016 and held it in 10 quarters. The position peaked at $521K in Q4 2023. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Quadrature Capital reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 14,296 Avanos Medical shares in Q1 2026, an estimated $161K.
  • Quadrature Capital first reported a position in Avanos Medical in Q3 2016 and held it in 10 quarters.
  • Quadrature Capital's Avanos Medical position peaked at $521K in Q4 2023.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.